Check nearby libraries
Buy this book
In the first study, OMA treatment in Zucker fatty rats resulted in significantly lower systolic blood pressure compared to the placebo-treated group. OMA did not enhance basal or insulin-stimulated IRS-1 tyrosine phosphorylation or its association with PI3-kinase. Under basal and insulin-stimulated conditions, OMA treatment did not alter protein mass or phosphorylation of Akt/PKB, p42/44 ERK or AMPK, or total GLUT4 protein expression. These findings suggest that OMA's ability to improve insulin-stimulated muscle glucose uptake in Zucker fatty rats is not mediated by enhancing insulin or AMPK-signaling.In the second study, ATORVA treatment resulted in an improvement in whole body insulin sensitivity in both lean and fatty Zucker rats, and an increase in 2-deoxyglucose uptake by skeletal muscles (quadriceps and gastrocnemius) of the Zucker lean rats. Insulin-stimulated phosphorylation of Akt/PKB was significantly increased in skeletal muscle of ATORVA-treated lean and fatty rats. We conclude that ATORVA induces insulin sensitization in Zucker lean and fatty rats and this is associated with augmented insulin-dependent Akt/PKB phosphorylation.
Check nearby libraries
Buy this book
Showing 1 featured edition. View all 1 editions?
Edition | Availability |
---|---|
1
Mechanisms of insulin sensitization by omapatrilat, a vasopeptidase inhibitor, and atorvastatin, a 3-hydroxyl-3-methylglutaryl coenzyme A reductase inhibitor.
2005
in English
0494075074 9780494075074
|
aaaa
Libraries near you:
WorldCat
|
Book Details
Edition Notes
Source: Masters Abstracts International, Volume: 44-02, page: 0738.
Thesis (M.Sc.)--University of Toronto, 2005.
Electronic version licensed for access by U. of T. users.
GERSTEIN MICROTEXT copy on microfiche (3 microfiches).
The Physical Object
ID Numbers
Community Reviews (0)
Feedback?January 24, 2010 | Edited by WorkBot | add more information to works |
December 11, 2009 | Created by WorkBot | add works page |